Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.17% |
| Sep 30, 2025 | 46.52% |
| Jun 30, 2025 | 14.73% |
| Mar 31, 2025 | 46.25% |
| Dec 31, 2024 | -555.76% |
| Sep 30, 2024 | -50.46% |
| Jun 30, 2024 | -37.29% |
| Mar 31, 2024 | 26.06% |
| Dec 31, 2023 | -102.17% |
| Sep 30, 2023 | 100.00% |
| Mar 31, 2023 | 77.97% |
| Dec 31, 2022 | 75,868.02% |
| Sep 30, 2022 | -8,109,137.82% |
| Mar 31, 2022 | -212.18% |
| Dec 31, 2021 | 217.06% |
| Sep 30, 2021 | -247.81% |
| Jun 30, 2021 | 62.58% |
| Mar 31, 2021 | -1,013.33% |
| Dec 31, 2020 | 80.92% |
| Sep 30, 2020 | 58.15% |